Oxidative stress in otosclerosis

Figures & data

Table 1 Parameters of otosclerosis patients and control individuals. OS: Otosclerosis patients

	Groups	N	Mean ± Standard deviation	P
Arylesterase	Control	50	147.02 ± 34.82	0.401
	OS	32	140.2410 ± 36.6192
LOOH	Control	50	5.12 ± 0.96	0.000
	OS	32	15.94 ± 4.78
TOS	Control	50	13.53 ± 3.30	0.000
	OS	32	26.15 ± 8.14
PON	Control	50	91.31 ± 22.32	0.013
	OS	32	79.86 ± 15.19
SH	Control	50	0.48 ± 0.06	0.003
	OS	32	0.43 ± 0.05
Cp	Control	50	795.08 ± 102.87	0.003
	OS	32	886.01 ± 162.63
TAS	Control	50	1.10 ± 0.19	0.001
	OS	32	0.94 ± 0.21
OSI	Control	50	1.24 ± 0.32	0.000
	OS	32	2.92 ± 1.26

Table 2 Differences according to gender (male versus female)

Gender difference among the levels of	@tas	@looh	@arylest	@sh	@osi	@serulop	@pon	@tos
Asymp. Sig. (2-tailed)	0.762	0.897	0.387	0.187	0.226	0.489	0.226	0.489